Medplus Health Services Ltd

Adverse Business Impact

Medplus Health Services Adverse Business Impact

MedPlus subsidiary Optival Health Solutions received a two-day drug license suspension order for a store in Jadcherla, Telangana. The suspension, effective from April 8, 2026, carries a negligible estimated revenue loss of ₹0.28 lacs (approximately ₹0.00 Crore) and follows alleged violations of the Drugs and Cosmetics Act, 1940.

Execution

2 days

Other Announcement

Medplus Health Services Other Announcement

MedPlus Health Services Limited submitted its quarterly compliance certificate under SEBI (DP) Regulations for the period ended March 31, 2026. The certificate, issued by KFin Technologies, confirms that security details for dematerialized/rematerialized shares were furnished to stock exchanges.

Adverse Business Impact

Medplus Health Services Adverse Business Impact

MedPlus Health Services' subsidiary, Optical Health Solutions, received a two-day drug license suspension for its Jangaon, Telangana store. Issued by the Drugs Control Administration for Rule 65 violations, the suspension carries a negligible estimated revenue impact of ₹0.00 Crore (Rs 0.16 lacs).

Execution

2 days